Patients’ Understanding of Risk Associated with Medication Use Dianne C. BerryD.K. RaynorElisabetta Bersellini Current Opinion 21 November 2012 Pages: 1 - 11
Cytochrome P450 Drug Interactions Within the HMG-CoA Reductase Inhibitor Class Jennifer MartinHenry Krum Leading Article 21 November 2012 Pages: 13 - 21
Benefit-Risk Assessment of Infliximab in the Treatment of Rheumatoid Arthritis Ted R. MikulsLarry W. Moreland Review Article 21 November 2012 Pages: 23 - 32
Aristolochic Acid and ‘Chinese Herbs Nephropathy’ Jean-Pierre Cosyns Review Article 21 November 2012 Pages: 33 - 48
Adverse Events Associated with Rofecoxib Therapy Bernard BannwarthRichard TrèvesMaxime Dougados Original Research Article 21 November 2012 Pages: 49 - 54
Benefits and Risks of Pharmacotherapy for Dysthymia Maurício S. De LimaMatthew Hotopf Original Research Article 21 November 2012 Pages: 55 - 64